Company: EDSA
Filing Date: 2025-12-12
Form Type: 8-K
Source: 0001171843-25-007918
Chunk: 1

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are furnished
with this Current Report on Form 8-K:

  Exhibit      Exhibit Description                                                                    
   Number                                                                                             
 ──────────────────────────────────────────────────────────────────────────────────────────────────────
      5.1      Opinion of Fasken Martineau DuMoulin LLP                                               
     23.1      Consent of Fasken Martineau DuMoulin LLP (included in Exhibit 5.1)                     
      104      Cover Page Interactive Data File (the cover page XBRL tags are embedded within in the  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               Edesa Biotech, Inc.                               
  Date: December 12, 2025      By:                      /s/ Peter Weiler         
                               Name:                    Peter Weiler             
                               Title:                   Chief Financial Officer